skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 191,864  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer’s disease
Material Type:
Article
Add to My Research

The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer’s disease

Proceedings of the National Academy of Sciences - PNAS, 2020-12, Vol.117 (50), p.32145-32154 [Peer Reviewed Journal]

Copyright © 2020 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences Dec 15, 2020 ;Copyright © 2020 the Author(s). Published by PNAS. 2020 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2009680117 ;PMID: 33257576

Full text available

2
Tau-targeting therapies for Alzheimer disease
Material Type:
Article
Add to My Research

Tau-targeting therapies for Alzheimer disease

Nature reviews. Neurology, 2018-07, Vol.14 (7), p.399-415 [Peer Reviewed Journal]

COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Jul 2018 ;ISSN: 1759-4758 ;EISSN: 1759-4766 ;DOI: 10.1038/s41582-018-0013-z ;PMID: 29895964

Full text available

3
Comprehensive Review on Alzheimer's Disease: Causes and Treatment
Material Type:
Article
Add to My Research

Comprehensive Review on Alzheimer's Disease: Causes and Treatment

Molecules (Basel, Switzerland), 2020-12, Vol.25 (24), p.5789 [Peer Reviewed Journal]

2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 1420-3049 ;EISSN: 1420-3049 ;DOI: 10.3390/molecules25245789 ;PMID: 33302541

Full text available

4
β-Amyloid accumulation in the human brain after one night of sleep deprivation
Material Type:
Article
Add to My Research

β-Amyloid accumulation in the human brain after one night of sleep deprivation

Proceedings of the National Academy of Sciences - PNAS, 2018-04, Vol.115 (17), p.4483-4488 [Peer Reviewed Journal]

Volumes 1–89 and 106–114, copyright as a collective work only; author(s) retains copyright to individual articles ;Copyright © 2018 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences Apr 24, 2018 ;Copyright © 2018 the Author(s). Published by PNAS. 2018 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1721694115 ;PMID: 29632177

Full text available

5
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease
Material Type:
Article
Add to My Research

A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease

Nature Medicine, 2021-07, Vol.27 (7), p.1187-1196 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to Springer Nature America, Inc. ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2021. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1078-8956 ;EISSN: 1546-170X ;EISSN: 1744-7933 ;DOI: 10.1038/s41591-021-01369-8 ;PMID: 34155411

Full text available

6
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Material Type:
Article
Add to My Research

High performance plasma amyloid-β biomarkers for Alzheimer's disease

Nature (London), 2018-02, Vol.554 (7691), p.249-254 [Peer Reviewed Journal]

Copyright Nature Publishing Group Feb 8, 2018 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature25456 ;PMID: 29420472

Full text available

7
Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer’s disease
Material Type:
Article
Add to My Research

Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer’s disease

Proceedings of the National Academy of Sciences - PNAS, 2016-10, Vol.113 (42), p.E6535-E6544 [Peer Reviewed Journal]

Volumes 1–89 and 106–113, copyright as a collective work only; author(s) retains copyright to individual articles ;Copyright National Academy of Sciences Oct 18, 2016 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1611073113 ;PMID: 27702899

Full text available

8
Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer's models
Material Type:
Article
Add to My Research

Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer's models

Nature medicine, 2019-01, Vol.25 (1), p.165-175 [Peer Reviewed Journal]

COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Jan 2019 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-018-0275-4 ;PMID: 30617325

Full text available

9
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study
Material Type:
Article
Add to My Research

Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study

Lancet neurology, 2021-09, Vol.20 (9), p.739-752 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;ISSN: 1474-4422 ;ISSN: 1474-4465 ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(21)00214-3 ;PMID: 34418401

Full text available

10
Mass spectrometry‐based methods for robust measurement of Alzheimer's disease biomarkers in biological fluids
Material Type:
Article
Add to My Research

Mass spectrometry‐based methods for robust measurement of Alzheimer's disease biomarkers in biological fluids

Journal of neurochemistry, 2021-10, Vol.159 (2), p.211-233 [Peer Reviewed Journal]

2021 International Society for Neurochemistry ;2021 International Society for Neurochemistry. ;Copyright © 2021 International Society for Neurochemistry ;ISSN: 0022-3042 ;EISSN: 1471-4159 ;DOI: 10.1111/jnc.15465 ;PMID: 34244999

Full text available

11
A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis
Material Type:
Article
Add to My Research

A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis

Molecular neurodegeneration, 2021-05, Vol.16 (1), p.30-12, Article 30 [Peer Reviewed Journal]

2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1750-1326 ;EISSN: 1750-1326 ;DOI: 10.1186/s13024-021-00451-6 ;PMID: 33933117

Full text available

12
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease
Material Type:
Article
Add to My Research

A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease

Nature Medicine, 2020-03, Vol.26 (3), p.398-407 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;COPYRIGHT 2020 Nature Publishing Group ;2020© The Author(s), under exclusive licence to Springer Nature America, Inc. 2020 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1078-8956 ;EISSN: 1546-170X ;EISSN: 1744-7933 ;DOI: 10.1038/s41591-020-0781-z ;PMID: 32161412

Full text available

13
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Material Type:
Article
Add to My Research

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

The New England journal of medicine, 2014-01, Vol.370 (4), p.322-333 [Peer Reviewed Journal]

Copyright © 2014 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;2014 Massachusetts Medical Society. 2014 ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1304839 ;PMID: 24450891 ;CODEN: NEJMAG

Full text available

14
Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer’s Disease
Material Type:
Article
Add to My Research

Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer’s Disease

Molecular neurobiology, 2018-07, Vol.55 (7), p.6076-6093 [Peer Reviewed Journal]

Springer Science+Business Media, LLC 2017 ;Molecular Neurobiology is a copyright of Springer, (2017). All Rights Reserved. ;ISSN: 0893-7648 ;EISSN: 1559-1182 ;DOI: 10.1007/s12035-017-0798-6 ;PMID: 29170981

Full text available

15
Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
Material Type:
Article
Add to My Research

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease

The New England journal of medicine, 2018-01, Vol.378 (4), p.321-330 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1705971 ;PMID: 29365294

Full text available

16
Altered static and dynamic functional network connectivity in Alzheimer's disease and subcortical ischemic vascular disease: shared and specific brain connectivity abnormalities
Material Type:
Article
Add to My Research

Altered static and dynamic functional network connectivity in Alzheimer's disease and subcortical ischemic vascular disease: shared and specific brain connectivity abnormalities

Human brain mapping, 2019-08, Vol.40 (11), p.3203-3221 [Peer Reviewed Journal]

2019 Wiley Periodicals, Inc. ;COPYRIGHT 2019 John Wiley & Sons, Inc. ;ISSN: 1065-9471 ;EISSN: 1097-0193 ;DOI: 10.1002/hbm.24591 ;PMID: 30950567

Full text available

17
A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease
Material Type:
Article
Add to My Research

A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease

Alzheimer's research & therapy, 2017-12, Vol.9 (1), p.95-95, Article 95 [Peer Reviewed Journal]

COPYRIGHT 2017 BioMed Central Ltd. ;COPYRIGHT 2017 BioMed Central Ltd. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s). 2017 ;ISSN: 1758-9193 ;EISSN: 1758-9193 ;DOI: 10.1186/s13195-017-0318-y ;PMID: 29221491

Full text available

18
High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer’s and Non-Alzheimer’s Disease Tauopathies
Material Type:
Article
Add to My Research

High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer’s and Non-Alzheimer’s Disease Tauopathies

Neuron (Cambridge, Mass.), 2021-01, Vol.109 (1), p.42-58.e8 [Peer Reviewed Journal]

2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Elsevier Inc. ;ISSN: 0896-6273 ;EISSN: 1097-4199 ;DOI: 10.1016/j.neuron.2020.09.042 ;PMID: 33125873

Full text available

19
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration
Material Type:
Article
Add to My Research

Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration

Nature medicine, 2020-03, Vol.26 (3), p.387-397 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;COPYRIGHT 2020 Nature Publishing Group ;2020© The Author(s), under exclusive licence to Springer Nature America, Inc. 2020 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-020-0762-2 ;PMID: 32123386

Full text available

20
Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer's disease
Material Type:
Article
Add to My Research

Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer's disease

Nature communications, 2020-11, Vol.11 (1), p.6129-6129, Article 6129 [Peer Reviewed Journal]

The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-19737-2 ;PMID: 33257666

Full text available

Results 1 - 20 of 191,864  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (156,942)

Refine My Results

Creation Date 

From To
  1. Before 1963  (28)
  2. 1963 To 1980  (221)
  3. 1981 To 1995  (15,141)
  4. 1996 To 2011  (57,567)
  5. After 2011  (118,846)
  6. More options open sub menu

Subject 

  1. Science & Technology  (125,860)
  2. Life Sciences & Biomedicine  (113,107)
  3. Alzheimer's Disease  (108,382)
  4. Humans  (79,964)
  5. Alzheimers Disease  (52,718)
  6. Neurosciences & Neurology  (51,606)
  7. Neurosciences  (46,938)
  8. Male  (41,152)
  9. Dementia  (36,025)
  10. Female  (35,001)
  11. Animals  (34,049)
  12. Aged  (32,763)
  13. Biological And Medical Sciences  (29,023)
  14. Medical Sciences  (27,640)
  15. Neurodegenerative Diseases  (27,282)
  16. Neurology  (23,837)
  17. Proteins  (22,846)
  18. Alzheimer’s Disease  (21,698)
  19. Cognitive Ability  (21,161)
  20. Clinical Neurology  (20,449)
  21. More options open sub menu

Language 

  1. English  (189,321)
  2. Japanese  (19,912)
  3. Spanish  (1,006)
  4. Portuguese  (906)
  5. French  (654)
  6. German  (500)
  7. Chinese  (289)
  8. Norwegian  (229)
  9. Russian  (158)
  10. Polish  (104)
  11. Persian  (97)
  12. Dutch  (79)
  13. Czech  (76)
  14. Catalan  (70)
  15. Korean  (68)
  16. Turkish  (58)
  17. Italian  (27)
  18. Croatian  (25)
  19. Swedish  (19)
  20. Bokmål, Norwegian  (8)
  21. More options open sub menu

Searching Remote Databases, Please Wait